The P1 plasmid addiction operon encodes Doc, a toxin that kills plasmi
d-free segregants, and Phd, an unstable antidote that neutralizes the
toxin, Additionally, these products repress transcription of the opero
n. The antidote binds to two adjacent sites in the promoter. Here we p
resent evidence concerning the regulatory role of the toxin, which we
studied with the aid of a mutation, docH66Y. The DocH66Y protein retai
ned the regulatory properties of the wild-type protein, but not its to
xicity, In vivo, DocH66Y enhanced repression by Phd but failed to affe
ct repression in the absence of Phd, suggesting that DocH66Y contacts
Phd. In vitro, a MalE-DocH66Y fusion protein was found to bind Phd. Bi
nding of toxin to antidote may be the physical basis for the neutraliz
ation of toxin. DocH66Y failed to hind DNA in vitro yet enhanced the a
ffinity, cooperativity, and specificity with which Phd hound the opera
tor, Although DocH66Y enhanced the binding of Phd to two adjacent Phd-
binding sites, DocH66Y had relatively little effect on the binding of
Phd to a single Phd-binding site, indicating that DocH66Y mediates coo
perative interactions between adjacent Phd-binding sites. Several elec
trophoretically distinct protein-DNA complexes were observed with diff
erent amounts of DocH66Y relative to Phd. Maximal repression and speci
ficity of DNA binding were observed with subsaturating amounts of DocH
66Y relative to Phd. Analogous antidote-toxin pairs appear to have sim
ilar autoregulatory circuits. Autoregulation, by dampening fluctuation
s in the levels of toxin and antidote, may prevent the inappropriate a
ctivation of the toxin.